Platelets (May 2022)

Congenital thrombocytopenia associated with a heterozygous variant in the MEIS1 gene encoding a transcription factor essential for megakaryopoiesis

  • Orna Steinberg-Shemer,
  • Naama Orenstein,
  • Tanya Krasnov,
  • Sharon Noy-Lotan,
  • Nathaly Marcoux,
  • Orly Dgany,
  • Joanne Yacobovich,
  • Oded Gilad,
  • Evelyn Shabad,
  • Lina Basel-Salmon,
  • Hannah Tamary

DOI
https://doi.org/10.1080/09537104.2021.1961704
Journal volume & issue
Vol. 33, no. 4
pp. 645 – 648

Abstract

Read online

The transcription factor MEIS1 (myeloid ectotrophic insertion site 1) is crucial for the maintenance of hematopoietic stem cells and for megakaryopoiesis. Germline variants in MEIS1 are associated with restless-leg syndrome, but were not previously shown to cause cytopenias. This is the first report of a patient with congenital thrombocytopenia associated with a sequence variant in MEIS1, presenting with early onset severe thrombocytopenia and mild signs of bone marrow stress. Whole exome sequencing revealed a de novo monoallelic splice site variant in MEIS1, NM_002398.3:exon4:c.432 + 5 G > C, leading to a premature stop codon. We propose that heterozygous mutations in MEIS1 may cause congenital thrombocytopenia.

Keywords